Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition or treatment. Clinical judgment must always be exercised in individual patient care decisions.

---

Neonatal Sepsis

Overview

• Definition: Neonatal sepsis is a systemic inflammatory response syndrome (SIRS) in an infant ≤28 days of age, due to a suspected or confirmed infection. It encompasses a wide spectrum of clinical signs, ranging from subtle changes to rapid progression to septic shock and multi-organ failure. It is typically classified based on the timing of onset relative to birth:
  • Early-onset sepsis (EOS): Occurs within the first 72 hours of life (some definitions extend this to ≤7 days of life).
  • Late-onset sepsis (LOS): Occurs after 72 hours of life (or >7 days) up to 28 days of life.
  • Very late-onset sepsis (VLOS): Sometimes used for infections occurring in preterm infants beyond 28 days of life, often in the setting of prolonged hospitalization in a neonatal intensive care unit (NICU).
• Epidemiology:
  • Incidence: Varies significantly by gestational age and region.
    • EOS: Approximately 0.5-1 per 1000 live births in term infants. Incidence is inversely related to gestational age, reaching 10-20 per 1000 live births in very low birth weight (VLBW, <1500g) infants.
    • LOS: Higher incidence in preterm infants, especially those in the NICU, ranging from 11-26% in VLBW infants.
  • Mortality: Significant cause of morbidity and mortality. Mortality rates for neonatal sepsis range from 10-50%, with higher rates in preterm infants and those with multi-drug resistant organisms or fungal infections. Sepsis accounts for 1.6 million neonatal deaths globally per year.
  • Common Pathogens:
    • EOS: Group B Streptococcus (GBS), Escherichia coli (E. coli), other Gram-negative enteric bacteria (e.g., Klebsiella, Enterobacter), Listeria monocytogenes.
    • LOS: Coagulase-negative Staphylococci (CoNS, common in NICU), Staphylococcus aureus (including MRSA), E. coli, Klebsiella, Pseudomonas aeruginosa, Enterococcus, Candida species.
• Classification: As described above, primarily by timing of onset (EOS vs. LOS), which guides differential diagnosis and empiric treatment strategies due to differing pathogen profiles and routes of acquisition.

Pathophysiology

• Mechanism: Neonates have an immature immune system, rendering them particularly vulnerable to overwhelming infection. Key immune deficits include:
  • Humoral Immunity: Reduced production of specific antibodies (IgM and IgG) and impaired complement activation, especially alternative pathway. Term infants acquire maternal IgG transplacentally, providing some passive immunity, but preterm infants have less.
  • Cellular Immunity: Impaired neutrophil chemotaxis, phagocytosis, and bacterial killing. Macrophages and dendritic cells also exhibit functional immaturity. Lymphocyte responses are also less robust.
  • Barrier Function: Immature skin and mucosal barriers in preterm infants allow easier pathogen entry. Gastric acidity is lower, reducing protection against ingested pathogens.
  • Inflammatory Response: Neonates may have a dysregulated inflammatory response, leading to exaggerated pro-inflammatory responses (cytokine storm) followed by immunosuppression, contributing to organ damage and susceptibility to secondary infections.
• Risk Factors:
  • Maternal Factors (primarily EOS):
    • Maternal intrapartum fever (≥38°C/100.4°F)
    • Prolonged rupture of membranes (PROM) ≥18 hours
    • Maternal GBS colonization without adequate intrapartum antibiotic prophylaxis (IAP)
    • Chorioamnionitis (clinical diagnosis: maternal fever, uterine tenderness, foul-smelling amniotic fluid, maternal or fetal tachycardia, leukocytosis)
    • Previous infant with invasive GBS disease
    • Maternal urinary tract infection (UTI)
  • Neonatal Factors (both EOS and LOS, more pronounced for LOS):
    • Prematurity (especially <34 weeks gestation)
    • Low birth weight (LBW, <2500g) and Very Low Birth Weight (VLBW, <1500g)
    • Invasive procedures: Endotracheal intubation, central venous catheters (umbilical, PICC lines), urinary catheters, parenteral nutrition.
    • Mechanical ventilation
    • Total parenteral nutrition (TPN)
    • Congenital anomalies (e.g., gastroschisis, meningomyelocele)
    • Immunodeficiency
    • Male sex (slightly higher risk)
    • Galactosemia (increased E. coli risk)
• Protective Factors:
  • Maternal Antibodies: Transplacental transfer of maternal IgG provides passive immunity against various pathogens.
  • Breastfeeding: Breast milk contains immunoglobulins (IgA), lactoferrin, lysozyme, and immune cells that provide passive immunity and promote beneficial gut microbiota.
  • Intact Skin Barrier: Healthy, mature skin prevents bacterial invasion.
  • Normal Gut Microbiota: Development of a healthy gut microbiome competes with pathogens.
  • Strict Adherence to Infection Control Practices: Hand hygiene, aseptic technique for procedures, judicious use of central lines and antibiotics in the NICU.

Clinical Presentation

Signs and Symptoms

Neonatal sepsis symptoms are often non-specific, subtle, and can rapidly progress. A high index of suspicion is critical. - Cardinal Features: * Temperature instability: Most common sign. Hypothermia (<36.5°C/97.7°F) is often more common and ominous than fever (≥38°C/100.4°F). * Lethargy/Irritability: Decreased activity, poor tone, weak cry, or excessive crying/fussiness. * Poor Feeding: Decreased oral intake, poor suck, vomiting, abdominal distension, reflux. * Respiratory Distress: Tachypnea (>60 breaths/min), grunting, flaring, retractions, apnea (pauses >20 seconds or shorter pauses with bradycardia/cyanosis). Apnea is a common initial sign in preterm infants. - Early Signs: * Subtle changes in behavior (e.g., not "looking right" to parents or nurses) * Mild temperature fluctuations * Mild changes in feeding pattern * Increased jaundice or failure of jaundice to resolve * Skin pallor or mottling * Jitteriness - Advanced Signs: Indicate severe infection and potential organ dysfunction. * Cardiovascular: Tachycardia (>160 bpm) or bradycardia (<100 bpm), hypotension, prolonged capillary refill time (>3 seconds), mottled skin, weak peripheral pulses, cyanosis. * Respiratory: Severe respiratory distress requiring mechanical ventilation, persistent pulmonary hypertension. * Neurological: Seizures, bulging fontanelle (meningitis), hypotonia, coma. * Gastrointestinal: Abdominal distension, bilious emesis, bloody stools (suggestive of necrotizing enterocolitis or severe gut ischemia). * Hematological: Petechiae, purpura, bleeding (suggestive of DIC). * Metabolic: Hypoglycemia or hyperglycemia, metabolic acidosis. - Atypical Presentations: * Isolated persistent unexplained hypoglycemia or hyperglycemia. * Unexplained metabolic acidosis. * Unexplained new onset of jaundice or hyperbilirubinemia after 24 hours. * Only symptom is a change in "behavior" or "activity" without other obvious signs. * Persistent unexplained bradycardia or desaturations.

Physical Examination

A thorough head-to-toe examination is crucial, looking for subtle clues of systemic illness or specific organ involvement. - Inspection: * General Appearance: Level of consciousness, activity, responsiveness to stimuli, posture, cry quality. * Skin: Color (pallor, cyanosis, mottling, jaundice), presence of rash (petechiae, purpura, vesicular lesions), poor skin turgor. * Respiratory: Respiratory rate, signs of distress (nasal flaring, grunting, retractions, apnea), symmetry of chest movement. * Neurological: Fontanelle (flat, sunken, bulging), pupillary response, spontaneous movements, presence of jitteriness, tremors, or seizures. * Abdomen: Distension, visible bowel loops, umbilical stump (redness, discharge, odor). - Palpation: * Pulses: Femoral and brachial pulses (rate, rhythm, quality – bounding, thready, weak). * Capillary Refill Time (CRT): Press on the sternum or sole of the foot for 5 seconds, release, and measure time for color to return. CRT >3 seconds is suggestive of poor perfusion. * Abdomen: Tenderness, masses, hepatosplenomegaly. * Temperature: Palpate extremities for coolness or warmth, indicating perfusion status. - Special Tests: There are no specific "special tests" in the physical exam for neonatal sepsis; rather, it involves a comprehensive systemic examination to identify potential source or extent of infection. This includes: * Auscultation of heart (murmurs, gallop) and lungs (rales, rhonchi, decreased breath sounds). * Assessment of hydration status (mucous membranes, skin turgor).

Diagnostic Approach

History Taking

• Key Questions:
  • Maternal History:
    • Gravida/Para, prenatal care, complications during pregnancy (e.g., gestational diabetes, pre-eclampsia).
    • Group B Streptococcus (GBS) screening status (positive, negative, unknown) and intrapartum antibiotic prophylaxis (IAP) details (type, dose, timing).
    • Rupture of membranes: Time of rupture, color of fluid, presence of meconium or foul odor.
    • Maternal fever during labor (>38°C/100.4°F) or signs of chorioamnionitis.
    • Maternal infections during pregnancy (e.g., UTI, HSV, HIV).
    • History of previous infant with invasive GBS disease.
  • Delivery History:
    • Gestational age, mode of delivery (vaginal, C-section).
    • Apgar scores, need for resuscitation.
  • Neonatal History:
    • Birth weight, post-natal weight changes, feeding patterns (volume, frequency, tolerance).
    • Changes in activity, cry, sleep-wake cycles.
    • Presence and progression of any signs/symptoms of sepsis.
    • Voiding and stool patterns.
    • Exposure history (e.g., sick contacts, visitors).
    • Presence of central lines or other invasive devices.
    • Any prior antibiotic exposure.
• Red Flags:
  • Maternal GBS positive with inadequate or no IAP.
  • PROM ≥18 hours.
  • Maternal intrapartum fever or clinical chorioamnionitis.
  • Preterm birth (<37 weeks gestation).
  • Any concerning clinical signs: temperature instability, apnea, respiratory distress, lethargy, poor feeding, hypotension, prolonged CRT.

Laboratory Tests

• First-Line: Rapid initiation of empiric antibiotics should not await full laboratory results if sepsis is clinically suspected.
  • Complete Blood Count (CBC) with Differential:
    • White Blood Cell (WBC) count: Can be high, low, or normal. Neither sensitive nor specific.
    • Absolute Neutrophil Count (ANC): Values <1,500 cells/µL (or <1,000 cells/µL) or >10,000-15,000 cells/µL can be concerning.
    • Immature to Total Neutrophil Ratio (I:T ratio): An I:T ratio >0.20-0.25 is highly suggestive of sepsis.
    • Platelet count: Thrombocytopenia (<100,000 cells/µL) can indicate sepsis or DIC.
  • C-reactive Protein (CRP): Acute phase reactant. Rises significantly 6-8 hours after infection onset, peaks at 24-48 hours.
    • Values >1.0 mg/dL (or >10 mg/L) are suggestive of sepsis.
    • Serial CRP measurements (e.g., at 0 and 8-24 hours) are more useful than a single value. A negative CRP at 24 hours often rules out bacterial sepsis.
  • Procalcitonin (PCT): Acute phase reactant. Rises earlier (within 2-4 hours) and peaks faster than CRP.
    • Values >0.5-2.0 ng/mL are often used as a cutoff, but values vary with age in the first 48-72 hours of life.
    • Can be useful in conjunction with CRP and clinical assessment for guiding antibiotic discontinuation.
  • Blood Culture: The gold standard for confirming bacterial sepsis.
    • Volume: Critically important. Aim for 0.5-1.0 mL blood per bottle. Two separate peripheral venipuncture sites are ideal if possible to distinguish true bacteremia from contamination, though often one peripheral site is used due to challenges in neonates.
    • Collection: Aseptic technique is paramount.
  • Cerebrospinal Fluid (CSF) Analysis and Culture: Lumbar puncture (LP) is recommended in all neonates suspected of sepsis, especially in preterm infants, those with clinical signs of meningitis, or if blood cultures are positive. Meningitis may be present in 25-30% of neonates with sepsis.
    • Analysis: WBC count (>20-30 cells/µL is concerning, but often lower in neonates), protein (>150 mg/dL), glucose (<50% of blood glucose, or <30-40 mg/dL).
    • Culture: Definitive diagnosis of meningitis.
  • Urine Culture: Recommended for all neonates with suspected late-onset sepsis (>72 hours of life) via catheterization or suprapubic aspiration. Bag samples are prone to contamination. Not routinely indicated for EOS.
  • Molecular tests: PCR for GBS, E. coli, etc., can provide rapid results, but sensitivity/specificity vary, and they are not yet standard for all sepsis evaluations.
• Confirmatory:
  • Positive blood, CSF, or urine culture identifying a pathogenic organism.
• Monitoring:
  • Serial CBC, CRP, and PCT levels can help assess response to therapy and guide duration of antibiotics.
  • Repeat cultures are generally not needed if clinical improvement occurs, but may be considered for resistant organisms, deep-seated infections, or persistent clinical signs.

Imaging

• Recommended:
  • Chest X-ray (CXR): Recommended for any neonate with respiratory symptoms (tachypnea, grunting, retractions, apnea) to evaluate for pneumonia, respiratory distress syndrome, or other pulmonary pathology.
• Advanced:
  • Cranial Ultrasound (CUS): Indicated for neonates with neurological symptoms (seizures, bulging fontanelle, focal neurological deficits) or confirmed meningitis, to evaluate for ventriculitis, abscess, or intracranial hemorrhage.
  • Abdominal X-ray: If abdominal distension, bilious emesis, or bloody stools are present, to rule out necrotizing enterocolitis (NEC) or other intestinal pathology.
  • Echocardiogram: If persistent hypotension unresponsive to fluid resuscitation and vasopressors, to assess cardiac function and rule out pericardial effusion.

Management

Acute Management

Prompt recognition and initiation of empiric broad-spectrum antibiotics are critical due to the rapid progression of neonatal sepsis. - Immediate (within 1 hour): * Fluid Resuscitation: For signs of poor perfusion or shock (e.g., prolonged CRT, hypotension). Initial bolus of 10-20 mL/kg of normal saline or crystalloid over 5-10 minutes. Repeat as needed, guided by clinical response. * Respiratory Support: Provide oxygen if SpO2 <90-92%. Initiate respiratory support (CPAP, mechanical ventilation) for significant respiratory distress or apnea. * Vascular Access: Establish reliable IV access (peripheral or umbilical venous catheter). * Empiric Antibiotics: Draw cultures (blood, CSF, urine if LOS) before administering antibiotics, but do not delay antibiotics awaiting lab results. * First-Line Empiric Regimen: * EOS (suspected maternal vertical transmission): Ampicillin + Gentamicin. This combination provides broad coverage against common EOS pathogens (GBS, E. coli, Listeria monocytogenes). * LOS (suspected nosocomial or community-acquired): Ampicillin + Cefotaxime or Ampicillin + Gentamicin + Vancomycin. Consider Vancomycin if MRSA is suspected or common in the unit, or if central line-associated bloodstream infection (CLABSI) is suspected. Cefotaxime is preferred over ceftriaxone in neonates due to risk of bilirubin displacement and biliary sludging. - Stabilization: * Temperature Control: Maintain normothermia (36.5-37.5°C). * Glucose Homeostasis: Monitor blood glucose closely. Treat hypoglycemia (<45 mg/dL) with IV dextrose bolus (D10W 2 mL/kg) followed by continuous infusion. * Blood Pressure Support: If hypotension persists despite adequate fluid resuscitation, consider inotropic support (e.g., dopamine, dobutamine, epinephrine, norepinephrine). * Electrolyte and Acid-Base Balance: Correct acidosis or electrolyte imbalances. - Emergency: * Septic Shock Management: Follow advanced resuscitation protocols (PALS/NRP guidelines) for fluid resuscitation, inotropes/vasopressors, and correction of metabolic derangements. * DIC Management: Transfusion of blood products (platelets for thrombocytopenia, fresh frozen plasma for coagulopathy) as indicated.

Chronic Management

• Pharmacological:
  • Antibiotic Dosing and Duration: Doses are weight, gestational age, and postnatal age dependent. Renal function also plays a role (e.g., gentamicin monitoring).
    • Ampicillin: 50-100 mg/kg/dose IV every 8-12 hours (frequency depends on gestational and postnatal age).
    • Gentamicin: 2.5-5 mg/kg/dose IV every 24-48 hours (frequency depends on gestational and postnatal age). Monitor peak and trough levels.
    • Cefotaxime: 50-75 mg/kg/dose IV every 8-12 hours.
    • Vancomycin: 10-15 mg/kg/dose IV every 8-24 hours. Monitor trough levels.
    • Duration:
      • Culture-negative, clinically suspected sepsis: 36-48 hours if cultures remain negative and CRP levels normalize. Some guidelines support discontinuation at 24 hours if initial workup is low risk and clinical condition improves.
      • Positive blood culture (uncomplicated bacteremia): 7-10 days.
      • Meningitis: 10-14 days for GBS, 14-21 days for Gram-negative organisms (e.g., E. coli). Consider repeating LP to confirm CSF sterilization for Gram-negative meningitis.
      • Specific infections: Necrotizing enterocolitis (NEC): 7-14 days. Osteomyelitis/Septic arthritis: 3-6 weeks.
  • Antifungal Agents: If fungal sepsis is suspected (e.g., prolonged hospitalization, TPN, broad-spectrum antibiotics, persistent sepsis signs without bacterial growth), start empiric Amphotericin B or Fluconazole.
• Non-pharmacological:
  • Nutritional Support: Ensure adequate caloric intake, either via enteral feeding (breast milk preferred) or parenteral nutrition if gut is compromised.
  • Central Line Management: Remove central venous catheters if they are the suspected source of infection, especially for CoNS or fungal infections.
  • Supportive Care: Pain management, comfort measures, strict infection control.
• Monitoring:
  • Daily clinical assessment for improvement or worsening of symptoms.
  • Serial inflammatory markers (CRP, PCT) to guide antibiotic duration.
  • Repeat cultures if no clinical improvement or if dealing with a difficult-to-treat organism.
  • Monitor complete blood counts, electrolytes, liver, and renal function.
  • Therapeutic drug monitoring (TDM) for drugs like gentamicin and vancomycin.

Treatment Algorithms

• First-Line:
  1. Suspected Sepsis: Draw blood culture (and CSF/urine if indicated), then immediately initiate empiric broad-spectrum antibiotics (Ampicillin + Gentamicin/Cefotaxime).
  2. Clinical Improvement & Negative Cultures (at 36-48 hours) & Normal Inflammatory Markers: Discontinue antibiotics.
  3. Positive Culture: De-escalate antibiotics to the narrowest spectrum agent based on sensitivity results. Continue for pathogen-specific duration.
• Second-Line:
  1. Clinical Deterioration on Empiric Therapy: Re-evaluate diagnosis, consider resistant organisms, fungal infection, viral infection, or non-infectious causes. Broaden antibiotic coverage (e.g., add Vancomycin, switch to Meropenem, add antifungal). Repeat cultures.
  2. Resistance Identified: Change antibiotics to appropriate agents based on sensitivity testing.
• Refractory Cases:
  1. No Bacterial Growth, but Persistent Signs: Consider viral infections (e.g., enterovirus, adenovirus, HSV), fungal infections, non-infectious inflammatory conditions (e.g., NEC, IVH), or drug fever.
  2. Persistent Bacteremia/Fungemia: Check for undrained foci of infection (e.g., abscess), remove infected central lines, confirm appropriate antibiotic dosing and penetration. Consult Infectious Disease.
  3. Shock Unresponsive to Fluid/Inotropes: Consider adrenal insufficiency (stress dose steroids), severe myocardial dysfunction.

Complications

• Common:
  • Respiratory distress syndrome (often exacerbated by sepsis)
  • Persistent pulmonary hypertension of the newborn (PPHN)
  • Necrotizing enterocolitis (NEC)
  • Chronic lung disease (bronchopulmonary dysplasia, BPD)
  • Intraventricular hemorrhage (IVH)
  • Periventricular leukomalacia (PVL)
  • Jaundice/Hyperbilirubinemia
  • Electrolyte disturbances (e.g., hyponatremia, hypoglycemia)
• Serious:
  • Meningitis: Particularly devastating, leading to severe neurodevelopmental impairment.
  • Septic Shock: Leading to multi-organ failure (renal failure, hepatic dysfunction, cardiovascular collapse).
  • Disseminated Intravascular Coagulation (DIC): Widespread microthrombi and bleeding.
  • Osteomyelitis/Septic arthritis
  • Death
• Long-term:
  • Neurodevelopmental Impairment: Cerebral palsy, cognitive delays, learning disabilities, hearing loss (especially with aminoglycoside use or meningitis), visual impairment.
  • Recurrent infections.
  • Chronic lung disease.
  • Renal insufficiency.
  • Hydrocephalus (post-meningitis).

Prognosis

• Factors:
  • Gestational Age and Birth Weight: Prematurity and very low birth weight are the strongest predictors of poor outcome and increased mortality.
  • Pathogen Virulence: Gram-negative bacteria (especially Pseudomonas, Klebsiella, E. coli) and fungi are associated with higher mortality and morbidity than GBS or CoNS. Listeria meningitis has a particularly poor prognosis.
  • Presence of Meningitis: Significantly worsens neurodevelopmental outcomes.
  • Clinical Severity: Presence of shock, multi-organ failure, or need for prolonged ventilatory support.
  • Timeliness of Diagnosis and Treatment: Prompt and appropriate antibiotic therapy improves outcomes.
• Survival: Varies widely. Mortality rates for EOS range from 1-5% in term infants but can be >20-30% in ELBW infants. LOS mortality rates can be up to 50% for fungal infections.
• Quality of Life: Neonatal sepsis, especially with meningitis or severe shock, is a major risk factor for adverse neurodevelopmental outcomes, including cerebral palsy, intellectual disability, hearing and visual impairments, and behavioral problems, leading to significant impact on long-term quality of life.

Prevention

• Primary: Aimed at preventing the initial occurrence of infection.
  • Maternal GBS Screening and Intrapartum Antibiotic Prophylaxis (IAP): Routine screening of pregnant women at 35-37 weeks gestation. Administer IV penicillin G or ampicillin to GBS-positive mothers during labor. This has significantly reduced EOS due to GBS.
  • Strict Hand Hygiene: For all healthcare workers and visitors in neonatal care units.
  • Aseptic Technique: Meticulous aseptic technique during all invasive procedures (e.g., central line insertion and care, intubation, lumbar punctures).
  • Judicious Use of Invasive Devices: Minimize use and duration of central venous catheters, endotracheal tubes, and urinary catheters.
  • Breastfeeding Promotion: Encourages passive immunity and beneficial gut colonization.
  • Environmental Control: Strict cleaning and disinfection protocols in NICUs.
  • Maternal Immunization: Influenza and Tdap vaccination in pregnancy can protect neonates.
• Secondary: Early detection and prompt intervention.
  • High Index of Suspicion: For any subtle changes in a neonate's clinical status.
  • Standardized Sepsis Evaluation Protocols: Implement clear guidelines for risk assessment and sepsis workup.
  • Rapid Initiation of Empiric Antibiotics: Do not delay treatment while awaiting culture results.
• Tertiary: Preventing complications and minimizing long-term sequelae.
  • Optimal Antibiotic Management: Tailored, appropriate duration of antibiotics.
  • Aggressive Supportive Care: Managing shock, respiratory failure, metabolic derangements.
  • Neurodevelopmental Follow-up: High-risk infants (preterm, severe sepsis, meningitis) should have long-term follow-up to identify and intervene early for developmental delays.

Special Populations

• Preterm Infants:
  • Higher Incidence: Due to immature immune systems and increased need for invasive procedures.
  • Atypical Presentation: Symptoms are often more subtle and non-specific.
  • Increased Severity: Higher risk of severe complications, multi-organ failure, and death.
  • Different Pathogens: LOS in preterm NICU infants is often caused by CoNS or fungi, and Gram-negatives can be highly resistant.
  • Dosing: Antibiotic dosing intervals are typically longer due to immature renal and hepatic function.
• Infants with Comorbidities:
  • Congenital Heart Disease: Increased risk of sepsis due to compromised circulation and potential for invasive procedures. Endocarditis risk.
  • Congenital Anomalies (e.g., gastroschisis, myelomeningocele): Open defects predispose to infection.
  • Immunodeficiencies: Primary immunodeficiencies (e.g., SCID, neutrophil disorders) make infants highly susceptible to severe, recurrent infections. Require specific diagnostic workup and tailored management, including consideration of IVIG or G-CSF.
  • Metabolic Disorders (e.g., Galactosemia): Increased susceptibility to specific pathogens (e.g., E. coli in galactosemia).

Clinical Pearls

• Diagnostic:
  • Think Sepsis First: Any acutely ill neonate, especially those with risk factors, should be presumed to have sepsis until proven otherwise. Err on the side of caution.
  • Non-specific Signs: Remember that "normal" vital signs or a single "normal" lab value do NOT rule out sepsis in neonates. Look for trends and subtle changes.
  • Serial Markers are Key: A single CRP or CBC can be misleading. Serial CRP and PCT are far more informative for diagnosis and guiding therapy.
  • Blood Culture is Gold Standard: Obtain adequate volume (0.5-1.0 mL) for blood cultures.
  • Lumbar Puncture: Do not hesitate to perform an LP, especially for LOS or any neurologic signs, as meningitis can be silent and devastating.
• Treatment:
  • Time is Tissue: Delay in antibiotic administration is associated with increased morbidity and mortality. Administer empiric antibiotics rapidly after cultures are drawn.
  • Tailor Therapy: Adjust antibiotic choice and duration based on culture results, sensitivities, and clinical response. De-escalation is important to reduce resistance and side effects.
  • Dose Appropriately: Neonatal physiology (volume of distribution, renal/hepatic clearance) differs significantly from older children and adults. Use specific neonatal dosing guidelines and monitor drug levels when appropriate.
• Pitfalls:
  • Over-reliance on Labs: Do not rely solely on normal WBC or initial negative CRP to rule out sepsis, especially early in the disease course.
  • Premature Discontinuation of Antibiotics: Risk of rebound sepsis or incomplete treatment. Always correlate lab normalization with clinical improvement.
  • Inadequate Culture Volume: Leads to false negatives.
  • Not Doing an LP: Missing meningitis can have severe long-term consequences.
  • Ignoring Maternal History: Crucial for assessing EOS risk and guiding empiric antibiotic choice.

Recent Updates

• Guidelines:
  • AAP Clinical Practice Guideline for Evaluation and Management of Infants 22 to 34 Weeks’ Gestation With Suspected Late-Onset Sepsis (2022): Emphasizes the role of CRP and PCT in guiding antibiotic duration, and the potential for a "watch and wait" approach in some stable low-risk preterm infants.
  • AAP Clinical Practice Guideline for the Management of Infants at Risk for Early-Onset Group B Streptococcal Disease (2019): Reaffirms the importance of maternal GBS screening and IAP, and provides updated risk-based management algorithms for infants.
• Evidence:
  • Role of Procalcitonin (PCT): Increasing evidence supports the use of serial PCT measurements, often in conjunction with CRP, as a tool to guide shorter antibiotic courses in culture-negative suspected sepsis, potentially reducing antibiotic exposure and resistance.
  • Reduced Duration of Antibiotics: Studies and guidelines increasingly support stopping antibiotics at 36-48 hours in culture-negative, clinically stable neonates, provided inflammatory markers normalize, reducing unnecessary antibiotic exposure and associated risks (e.g., dysbiosis, antifungal use).
• Controversies:
  • Optimal Duration of Antibiotics for Culture-Negative Sepsis: While 36-48 hours is common, some advocate for 24-hour discontinuation in very low-risk cases, while others prefer 72 hours.
  • Universal Lumbar Puncture for all Suspected LOS: While many advocate for LP in all LOS evaluations due to the risk of silent meningitis, debates continue regarding specific patient populations where it might be safely omitted (e.g., clinically well, older infants with negative blood cultures).
  • Utility of Specific Inflammatory Markers: Ongoing research to identify more sensitive and specific biomarkers for early diagnosis of sepsis, and their integration into clinical algorithms.

Key References

• Guidelines:
  • Pati S, et al. Management of Infants at Risk for Early-Onset Group B Streptococcal Disease. Pediatrics. 2019 Jun;143(6):e20190779. (American Academy of Pediatrics)
  • Polin RA, et al. Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics. 2010 Sep;126(3):454-463. (American Academy of Pediatrics - While older, foundational)
  • Puopolo KM, et al. Management of Infants 22 to 34 Weeks' Gestation With Suspected Late-Onset Sepsis. Pediatrics. 2022 Dec 1;150(6):e2022060000. (American Academy of Pediatrics)
  • CDC. Prevention of Perinatal Group B Streptococcal Disease. Updated Guidelines. MMWR Recomm Rep. 2010;59(RR-10):1-32.
• Studies/Reviews:
  • Stoll BJ, et al. Neonatal sepsis: Epidemiology and strategies for prevention. J Pediatr. 2004 Mar;144(3):395-403.
  • Shane AL, et al. Neonatal Sepsis: Epidemiology, Pathogenesis, and Management. Lancet Infect Dis. 2017 Mar;17(3):e128-e144.
  • Sharma D, et al. Biomarkers for Diagnosis of Neonatal Sepsis: A Systematic Review. J Matern Fetal Neonatal Med. 2017 Jul;30(13):1538-1544.
  • Schelonka RL, et al. The effect of birth weight and gestational age on the normal absolute neutrophil count in the first 60 days of life. J Perinatol. 2001 Jun;21(4):226-31.